Sharon F. Terry

Credentials: CEO, Genetic Alliance and CEO, PXE InternationalBio: Sharon F. Terry is President and CEO of Genetic Alliance, a network of more than 10,000 organizations, of which 1,200 are disease advocacy organizations.  Genetic Alliance enables individuals, families and communities to reclaim their health and become full participants in translational research and services. She is the founding CEO of PXE International, a research advocacy organization for the genetic condition pseudoxanthoma elasticum (PXE). As co-discoverer of the gene associated with PXE, she holds the patent for ABCC6 to act as its steward and has assigned her rights to the foundation.  She developed a diagnostic test and conducts clinical trials.  She is the author of 120 peer-reviewed papers, of which 30 are PXE clinical studies. Terry is also a co-founder of the Genetic Alliance Registry and Biobank.  In her focus at the forefront of consumer participation in genetics research, services and policy, she serves in a leadership role on many of the major international and national organizations, including the Institute of Medicine (IOM) Science and Policy Board, the IOM Roundtable on Translating Genomic-Based Research for Health, the PubMed Central National Advisory Committee, the International Rare Disease Research Consortium Executive Committee and as Founding President of EspeRare Foundation. She is on the editorial boards of several journals. She was instrumental in the pas...
Source: PHRMA - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

Org. Biomol. Chem., 2020, Accepted Manuscript DOI: 10.1039/D0OB00333F, PaperMohit Jaiswal, Sanyong Zhu, Wenjie Jiang, Zhongwu Guo Two myo-inositol derivatives having a removable N α,Nε-diacetyl-L-lysine (Ac2Lys) moiety linked to the inositol 1-O-position through a self-cleavable linker and a metabolically stable 2-azidoethyl group linked to the inositol 3-O- and... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Organic and Biomolecular Chemistry - Category: Molecular Biology Authors: Source Type: research
Pomalidomide is potentially a less painful alternative to options such as freezing and laser ablation, and it may have a lower rate of recurrence, but copays cost about $5000 for a month's supply.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Hematology-Oncology News Source Type: news
Authors: Goto T, Miyamoto H PMID: 32208041 [PubMed - as supplied by publisher]
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
Authors: Colacurci N, Schettino MT, Grimaldi V, De Luca FP, Mansueto G, Costa D, Cacciatore F, De Franciscis P, Napoli C Abstract The aim of this study was to characterize both by flow cytometry analysis and immunohistochemistry cervix uteri cells of nulliparous women screened for cervical intraepithelial neoplasia (CIN) in comparison to a group without CIN by using mesenchymal stem cell-like and hematopoietic lineage markers. A significant expression for CD29, CD38, HLA-I and HLA-II was correlated positively to the CIN degree and it was more relevant in patients positive for human papilloma virus (HPV). Thus, iden...
Source: Cancer Investigation - Category: Cancer & Oncology Tags: Cancer Invest Source Type: research
Publication date: Available online 26 March 2020Source: European Journal of Surgical OncologyAuthor(s): F. Meani, T. Kovacs, T. Spanic, A. Costa
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
ConclusionPretreatment SUVmax‐PT (median cut‐off 11.6) may have a prognostic value of OS and PFS in patients with TNM staged I‐III SCLC.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tags: ORIGINAL ARTICLE Source Type: research
Publication date: Available online 27 March 2020Source: Journal of the American College of RadiologyAuthor(s): Claire C. Conley, Bethany L. Niell, Bianca M. Augusto, McKenzie McIntyre, Richard Roetzheim, Kimberly Funaro, Susan T. Vadaparampil
Source: Journal of the American College of Radiology - Category: Radiology Source Type: research
Publication date: Available online 27 March 2020Source: Academic RadiologyAuthor(s): Harrison Kim, John V. Thomas, Jeffrey W. Nix, Jennifer B. Gordetsky, Yufeng Li, Soroush Rais-Bahrami
Source: Academic Radiology - Category: Radiology Source Type: research
Conclusions: In a supervised practice, PAs performed on par with their gastroenterology colleagues on established colonoscopy quality indicators. Following proper training, PAs can be employed in the provision of screening colonoscopy.
Source: Journal of the American Academy of Physician Assistants - Category: Primary Care Tags: Original Research Source Type: research
Researchers from Brazil have developed a way to visualize and interact with...Read more on AuntMinnie.comRelated Reading: AR equipped to 'transform' image-guided interventions AR, 3D printing make waves in cardiac care AR offers 3D image guidance for interventional procedures AR, 3D printing enhance planning for complex heart surgery AR, 3D printing aid presurgical planning for kidney cancer
Source: Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Genetics | Health | Pharmaceuticals | Pseudoxanthoma Elasticum | Rare Diseases | Science | Study